<div><p>The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. <i>Alu</i> and long interspersed nucleotide element-1 (<i>LINE-1</i>) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of <i>Alu</i> and <i>LINE-1</i> hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of <i>Alu</i> and <i>LINE-1</i> in 145 cases of breast samples including normal breas...
INTRODUCTION: DNA methylation is a well-studied biomarker in invasive breast cancer, but its role in...
Alterations in DNA methylation in cancer include global hypomethylation and gene-specific hypermethy...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...
The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promo...
Background: Promoter hypermethylation and global hypomethylation in the human genome are hallmarks o...
<div><p>Oncogenic transformation of normal cells often involves epigenetic alterations, including hi...
DNA methylation is the major repression mechanism for human retrotransposons, such as the Alu family...
Introduction: Five different molecular subtypes of breast cancer have been identified through gene e...
Background:Many breast cancer tumor suppressor genes have been reported to undergo hypermethylation,...
Abstract Background Breast cancer is a highly heterogeneous disease resulting in diverse clinical be...
<p>(A) <i>Alu</i> methylation levels are not different among the four groups of breast lesions. (B) ...
The highly repetitive Alu retroelements are regarded as methylation centres in the genome. Methylati...
poster abstractBreast Cancer is the most frequently diagnosed cancer among women worldwide. Accordin...
Background: Alu methylation is correlated with the overall level of DNA methylation and recombinatio...
The diversity of breast cancers reflects variations in underlying biology and affects the clinical i...
INTRODUCTION: DNA methylation is a well-studied biomarker in invasive breast cancer, but its role in...
Alterations in DNA methylation in cancer include global hypomethylation and gene-specific hypermethy...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...
The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promo...
Background: Promoter hypermethylation and global hypomethylation in the human genome are hallmarks o...
<div><p>Oncogenic transformation of normal cells often involves epigenetic alterations, including hi...
DNA methylation is the major repression mechanism for human retrotransposons, such as the Alu family...
Introduction: Five different molecular subtypes of breast cancer have been identified through gene e...
Background:Many breast cancer tumor suppressor genes have been reported to undergo hypermethylation,...
Abstract Background Breast cancer is a highly heterogeneous disease resulting in diverse clinical be...
<p>(A) <i>Alu</i> methylation levels are not different among the four groups of breast lesions. (B) ...
The highly repetitive Alu retroelements are regarded as methylation centres in the genome. Methylati...
poster abstractBreast Cancer is the most frequently diagnosed cancer among women worldwide. Accordin...
Background: Alu methylation is correlated with the overall level of DNA methylation and recombinatio...
The diversity of breast cancers reflects variations in underlying biology and affects the clinical i...
INTRODUCTION: DNA methylation is a well-studied biomarker in invasive breast cancer, but its role in...
Alterations in DNA methylation in cancer include global hypomethylation and gene-specific hypermethy...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...